Universal Health Realty Trust Reports Q1 Earnings

Written by Emily J. Thompson, Senior Investment Analyst

Source: PRnewswire

Updated: Apr 27 2026

0mins

UHT-0.22%

Should l Buy UHT?

Source: PRnewswire

Net Income Growth: For Q1 2026, Universal Health Realty reported a net income of $5 million, or $0.36 per diluted share, reflecting an increase from $4.8 million and $0.34 per diluted share in Q1 2025, primarily driven by reduced interest expenses and increased property income, thereby enhancing the company's profitability.
Funds from Operations Performance: The FFO for the first quarter was $12.3 million, or $0.88 per diluted share, up from $11.9 million and $0.86 per diluted share in Q1 2025, indicating significant operational efficiency improvements amid rising revenues and depreciation expenses.
Dividend Payment Update: A dividend of $0.745 per share, totaling $10.3 million, was declared for Q1 2026 and paid on March 31, demonstrating the company's ongoing commitment to stable cash flow and shareholder returns.
Credit Agreement Amendment: In April 2026, the company increased its borrowing capacity under its credit agreement from $425 million to $475 million, with the maturity date remaining unchanged at September 30, 2028, enhancing financial flexibility and supporting future investment strategies.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy UHT?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on UHT

About UHT

Universal Health Realty Income Trust is a real estate investment trust. The Company invests in healthcare and human service related facilities, including acute care hospitals, behavioral healthcare hospitals, specialty facilities, free-standing emergency departments, childcare centers and medical/office buildings. The Company has approximately 76 real estate investments or commitments located in 21 states in the United States consisting of six hospital facilities including three acute care and three behavioral healthcare; 60 medical/office buildings; four free-standing emergency departments; four preschool and childcare centers; one specialty facility located in Evansville, Indiana, and one property comprised of vacant land located in Chicago, Illinois. Its facilities include McAllen Medical Center, Wellington Regional Medical Center, Aiken Regional Medical Center, Canyon Creek Behavioral Health, Clive Behavioral Health, Desert Valley Medical Center and Danbury Medical Plaza.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Universal Health REIT Reports Q1 Earnings

Apr 27 2026seekingalpha

Earnings Per Share: Universal Health REIT reported a Q1 GAAP EPS of $0.36, indicating resilience in maintaining profitability despite economic fluctuations, which is crucial for investor confidence in uncertain markets.
Slight Revenue Decline: The revenue for the first quarter was $24.53 million, reflecting a minor year-over-year decrease of 0.1%, suggesting that increased competition in the healthcare REIT sector may pressure future revenue growth, warranting close monitoring of market trends.
Investor Appeal: Universal Health REIT is viewed as a solid income investment through economic cycles, highlighting its stable cash flow and dividend policy, which may attract income-seeking investors and enhance its market appeal.
Financial Transparency: The company has provided comprehensive financial information and historical earnings data, which boosts investor confidence in its financial health and offers potential investors a solid basis for decision-making, thereby increasing market interest in its stock.

Universal Health Services Reports Strong Q1 2026 Financial Results

Apr 27 2026PRnewswire

Net Income Growth: In Q1 2026, Universal Health Services reported net income of $348.7 million, or $5.65 per diluted share, compared to $316.7 million and $4.80 per diluted share in Q1 2025, indicating a significant improvement in profitability and reflecting strong performance in the healthcare sector.
Significant Revenue Increase: The net revenues for Q1 2026 reached $4.495 billion, a 9.6% increase year-over-year, demonstrating sustained demand in acute care and behavioral health services, which enhances the company's competitive position in the industry.
Strong EBITDA Performance: The EBITDA for Q1 2026 was $651.7 million, up 9.5% from $603.9 million in Q1 2025, showcasing ongoing improvements in operational efficiency and cost control, further solidifying the company's financial health.
Robust Cash Flow: The net cash provided by operating activities for Q1 2026 was $402 million, an increase of $42 million from $360 million in 2025, reflecting significant enhancements in cash management and operational efficiency, thereby strengthening the company's capacity for future investments and expansion.